Accepted for/Published in: JMIR Mental Health
Date Submitted: Apr 11, 2021
Date Accepted: May 13, 2021
Empowering Anxious Parents to Manage Child Avoidance Behaviors: Randomized Control Trial of a Single-Session Intervention for Parent Accommodation
ABSTRACT
Background:
A majority of youth who need anxiety treatment never access support. This disparity reflects a need for more accessible, scalable interventions—particularly those that may prevent anxiety in high-risk children, mitigating future need for higher-intensity care. Self-guided single-session interventions (SSIs) may offer a promising path toward this goal, given their demonstrated clinical utility, potential for disseminability, and low-cost. However, existing self-guided SSIs have been designed for completion by adolescents already experiencing symptoms, and their potential for preventing anxiety in children—for instance, by mitigating known anxiety risk factors—remains unexplored.
Objective:
This trial evaluated the acceptability and proximal effects of Project EMPOWER: a web-based, self-guided SSI designed to reduce parent accommodation, a parenting behavior known to increase anxiety risk in offspring.
Methods:
301 parents reporting elevated anxiety symptoms (98.01% mothers) with children ages 4-10 received either Project EMPOWER or an informational control (containing psychoeducational materials and resources); parents self-reported their accommodation of child anxiety and overall distress tolerance at baseline and 2-week follow-up.
Results:
Relative to control-group parents, parents who received Project EMPOWER reported significant reductions in their accommodation of child anxiety (d_s=0.61, p<.001), as well as significant increases in their distress tolerance〖(d〗_s=0.43, p<.001), from baseline to 2-week follow-up. Additionally, parents who completed Project EMPOWER rated it as highly acceptable (e.g., easy to use, helpful, engaging) per pre-registered benchmarks.
Conclusions:
Project EMPOWER is an acceptable self-guided SSI for parents of children at-risk for anxiety, yielding proximal reductions in clinically-relevant targets. Clinical Trial: NCT04453865
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.